Condition: Drug-drug Interaction · Liver Transplantation · Sponsor: Pontificia Universidad Catolica de Chile
The goal of this observational study is to enhance the ability to forecast kidney failure in liver transplant patients in the ICU under multidrug treatment by developing a computer platform that integrates mathematical models of drug interactions, proteomics, and clinical data. The main outcomes it aims to develop are: 1. Design the multidrug web computing platform with available information on drug pair interactions (DDIs). 2. Integrate the proteomic and clinical data of liver transplant patients into the IT platform. 3. Implement the multidrug web platform to predict the clinical evolution of liver transplant patients.
This description comes directly from the study's public registry record.
Nelson Barrera, PhD · 56987687058 · nbarrerr@uc.cl
Always discuss trial participation with your own doctor first.
| Hospital ClínicoUC-Christus | Santiago, Santiago Metropolitan, Chile | Recruiting |
| Pontificia Universidad Católica de Chile | Santiago, Santiago Metropolitan, Chile | Active Not Recruiting |
| Universidad de Valparaíso | Valparaíso, Valparaiso, Chile | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06682325